European Radiology

, Volume 20, Issue 5, pp 1069–1072 | Cite as

Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures

  • S. M. Stivaros
  • L. R. Williams
  • C. Senger
  • L. Wilbraham
  • Hans-Ulrich Laasch



We present our initial experience with a new biodegradable (BD) esophageal stent in two patients, one for a therapy-resistant benign esophageal stricture, and the other as a temporary measure during curative radiotherapy for oesophageal carcinoma.


The BD stents need to be loaded into a conventional pull-back delivery system but are then placed in a standard fashion. Pre-dilatation should be avoided to reduce the risk of migration, however if migration occurs the stents can be left to dissolve in the stomach. The stents are radiolucent but easily identified on CT with minimal artefact and thus might even aid with radiotherapy planning.


BD stents offer an exciting new strategy for therapy-resistant benign strictures as well as a supportive measure for oesophageal cancer undergoing non-surgical treatment.


Dilatation Endoscopy Oesophageal stenosis Oesophageal neoplasms Stents Biodegradable 


  1. 1.
    Song HY, Park SI, Do YS et al (1997) Expandable metallic stent placement in patients with benign esophageal strictures: results of long-term follow-up. Radiology 203:131–136PubMedGoogle Scholar
  2. 2.
    Cwikiel W, Willen R, Stridbeck H, Lillo-Gil R, von Holstein CS (1993) Self-expanding stent in the treatment of benign esophageal strictures: experimental study in pigs and presentation of clinical cases. Radiology 187:667–671PubMedGoogle Scholar
  3. 3.
    Dua KS, Vleggaar FP, Santharam R, Siersema PD (2008) Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study. Am J Gastroenterol 103:2988–2994CrossRefPubMedGoogle Scholar
  4. 4.
    Siersema PD (2008) Treatment options for esophageal strictures. Nat Clin Pract Gastroenterol Hepatol 5:142–152CrossRefPubMedGoogle Scholar
  5. 5.
    Repici A, Conio M, De Angelis C et al (2004) Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc 60:513–519CrossRefPubMedGoogle Scholar
  6. 6.
    Fry SW, Fleischer DE (1997) Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 45:179–182CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka T, Takahashi M, Nitta N et al (2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74:199–205PubMedGoogle Scholar
  8. 8.
    Zilberman M, Nelson KD, Eberhart RC (2005) Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. J Biomed Mater Res B Appl Biomater 74:792–799PubMedGoogle Scholar
  9. 9.
    Bell JK, Laasch HU, Wilbraham L, England RE, Morris JA, Martin DF (2004) Bispectral index monitoring for conscious sedation in intervention: better, safer, faster. Clin Radiol 59:1106–1113CrossRefPubMedGoogle Scholar
  10. 10.
    British Society of Interventional Radiology (BSIR) (2004) ROST—Registry of Oesophageal Stenting, first report 2004. Dendrite Clinical Systems, Henley-on-ThamesGoogle Scholar
  11. 11.
    Siersema PD (2009) Stenting for benign esophageal strictures. Endoscopy 41:363–373CrossRefPubMedGoogle Scholar
  12. 12.
    Zhong J, Wu Y, Xu Z, Liu X, Xu B, Zhai Z (2003) Treatment of medium and late stage esophageal carcinoma with combined endoscopic metal stenting and radiotherapy. Chin Med J (Engl) 116:24–28Google Scholar
  13. 13.
    Shin JH, Song HY, Kim JH et al (2005) Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J Vasc Interv Radiol 16:67–74PubMedGoogle Scholar
  14. 14.
    Lecleire S, Di Fiore F, Ben-Soussan E et al (2006) Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Aliment Pharmacol Ther 23:1693–1702CrossRefPubMedGoogle Scholar
  15. 15.
    Iraha Y, Murayama S, Toita T et al (2006) Self-expandable metallic stent placement for patients with inoperable esophageal carcinoma: investigation of the influence of prior radiotherapy and chemotherapy. Radiat Med 24:247–252CrossRefPubMedGoogle Scholar
  16. 16.
    Cruz I, Mamel JJ, Brady PG, Cass-Garcia M (2005) Incidence of abdominal wall metastasis complicating PEG tube placement in untreated head and neck cancer. Gastrointest Endosc 62:708–711 quiz 752, 753CrossRefPubMedGoogle Scholar
  17. 17.
    Wacke W, Hecker U, Woenckhaus C, Lerch MM (2004) Percutaneous endoscopic gastrostomy site metastasis in a patient with esophageal cancer. Endoscopy 36:472CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2009

Authors and Affiliations

  • S. M. Stivaros
    • 1
  • L. R. Williams
    • 1
  • C. Senger
    • 1
  • L. Wilbraham
    • 2
  • Hans-Ulrich Laasch
    • 1
  1. 1.Department of RadiologyThe Christie NHS Foundation TrustManchesterUK
  2. 2.Department of Nutrition and DieteticsThe Christie NHS Foundation TrustManchesterUK

Personalised recommendations